Bulletin
Investor Alert

London Markets Close in:

Incyte Corp.

NAS: INCY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204510994/composite

$

107.25

Change

+0.78 +0.73%

Volume

Volume 91,493

Jul 2, 2020, 6:23 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204510994/composite

Previous close

$ 102.65

$ 106.47

Change

+3.82 +3.72%

Day low

Day high

$102.52

$107.38

Open
Open: 102.82

52 week low

52 week high

$62.48

$110.25

Open

Market cap

$23.14B

Average volume

1.61M

P/E ratio

N/A

Rev. per Employee

$1.38M

EPS

-1.74

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/incy

MarketWatch News on INCY

  1. Lilly Is Testing Its Arthritis Drug as a Coronavirus Treatment

    8:41 a.m. June 15, 2020

    - Barron's Online

  2. Eli Lilly enrolls first patient in phase 3 trial of Olumiant for hospitalized patients with COVID-19

    6:49 a.m. June 15, 2020

    - Tomi Kilgore

  3. Eli Lilly's Olumiant is approved in 70 countries to treat rheumatoid arthritis

    6:50 a.m. June 15, 2020

    - Tomi Kilgore

  4. Incyte downgraded to neutral from overweight at J.P. Morgan

    6:48 a.m. May 6, 2020

    - Tomi Kilgore

  5. Activision Blizzard’s Play for a Pandemic Premium

    6:19 a.m. May 2, 2020

    - Barron's Online

  6. Incyte, Novartis launch drug study to treat coronavirus complication

    4:49 p.m. April 17, 2020

    - Wallace Witkowski

  7. A Blood Test That Could Get America Back to Work

    2:47 p.m. April 4, 2020

    - Barron's Online

  8. Incyte stock price target cut to $85 from $99 at Oppenheimer

    10:07 a.m. March 25, 2020

    - Tomi Kilgore

  9. The U.S. Is Coming Up Short in Its Response to Coronavirus

    12:49 p.m. March 14, 2020

    - Barron's Online

  10. 20 Years Later, Tech Bubble Still Offers Lessons for Investors

    9:30 p.m. March 13, 2020

    - Barron's Online

  11. Loading more headlines...
/news/nonmarketwatch/company/us/incy

Other News on INCY

  1. Nasdaq Continues to Excel : 5 Best Stocks in ETF

    12:05 p.m. June 22, 2020

    - Zacks.com

  2. Incyte (INCY) Looks Good: Stock Adds 8.3% in Session

    8:36 a.m. June 22, 2020

    - Zacks.com

  3. Alpine Skyrockets on License Deal With AbbVie for ALPN-101

    11:27 a.m. June 19, 2020

    - Zacks.com

  4. Incyte (INCY) Gets a Buy Rating from William Blair

    4:24 a.m. June 17, 2020

    - SmarterAnalyst

  5. Oppenheimer Issues a Buy Rating on Incyte (INCY)

    12:07 p.m. June 15, 2020

    - SmarterAnalyst

  6. Lilly launches late-stage study of baricitinib in COVID-19

    7:45 a.m. June 15, 2020

    - Seeking Alpha

  7. Small Caps Build Steam And Biotechs Remain Well-Positioned

    10:15 a.m. June 10, 2020

    - Seeking Alpha

  8. ACADIA Pharmaceuticals: The Worst-Case Scenario For Investors

    8:01 p.m. June 7, 2020

    - Seeking Alpha

  9. Why Is Incyte (INCY) Up 2.9% Since Last Earnings Report?

    11:31 a.m. June 4, 2020

    - Zacks.com

  10. Loading more headlines...
/news/pressrelease/company/us/incy

Press Releases on INCY

  1. Incyte Launches New Global Responsibility Section on Incyte.com

    8:00 a.m. June 15, 2020

    - BusinessWire - BZX

  2. Nasdaq 100 Movers: ATVI, MCHP

    10:31 a.m. June 3, 2020

    - MarketNewsVideo.com

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.